Global CRO Parexel International has opened a new office in Shenyang, China, to support growing client demand for a broad range of clinical development capabilities throughout the Asia Pacific region. The office expands Parexel's presence in China, which includes locations in Beijing, Chengdu, Guangzhou, Shanghai and Hong Kong. PAREXEL now has 22 offices in the Asia Pacific region, including in Australia, Japan, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.
"Given the globalization of clinical trials today and the continuing shift of drug development activity from West to East, China has become an important strategic destination for Parexel's clients and business," said Mark Goldberg, president and COO. "The office also further reinforces our social investment in the region through a collaboration with Shenyang Pharmaceutical University to train graduates on clinical trial conduct, data management and pharmacovigilance knowledge."
The Shenyang office also enables the company to bring Perceptive eClinical technology solutions to the Asia Pacific market. Built on the MyTrials platform, sponsors can manage the clinical development process from study design to data collection to regulatory submission.
Parexel Academy will offer graduates and alumni of Shenyang Pharmaceutical University's School of Life Science and Biopharmaceuticals opportunities to work alongside Parexel staff involved in regional and global clinical studies.
"The collaboration will not only provide our clinical pharmacy students the opportunity to learn about new drug development, but it will also create a foundation for research and cultivation of the next generation of talent." said Professor Jing-Yu Yang, Dean of Shenyang Pharmaceutical University.